X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10) 10
humans (8) 8
hematology (7) 7
multiple myeloma (6) 6
oncology (6) 6
transplantation (6) 6
animals (5) 5
mice (5) 5
abridged index medicus (4) 4
cancer (4) 4
chemotherapy (4) 4
health aspects (4) 4
in-vivo (4) 4
risk factors (4) 4
adult (3) 3
aged (3) 3
article (3) 3
female (3) 3
gene expression (3) 3
gene-expression (3) 3
genetic aspects (3) 3
male (3) 3
medicine, research & experimental (3) 3
mice, inbred c57bl (3) 3
middle aged (3) 3
multiple myeloma - drug therapy (3) 3
mutation (3) 3
research (3) 3
research article (3) 3
stem cells (3) 3
acute myeloid-leukemia (2) 2
aged, 80 and over (2) 2
base sequence (2) 2
blotting, western (2) 2
bone (2) 2
bone marrow - pathology (2) 2
boronic acids - administration & dosage (2) 2
bortezomib (2) 2
care and treatment (2) 2
cell proliferation - drug effects (2) 2
cells (2) 2
complications and side effects (2) 2
differentiation (2) 2
expression (2) 2
gene mutations (2) 2
hemic and lymphatic diseases (2) 2
immunology (2) 2
leukemia, myeloid, acute - genetics (2) 2
molecular sequence data (2) 2
multiple myeloma - metabolism (2) 2
multiple myeloma - pathology (2) 2
myelodysplastic syndromes (2) 2
myelodysplastic syndromes - genetics (2) 2
pyrazines - administration & dosage (2) 2
survival (2) 2
survival analysis (2) 2
therapy (2) 2
usage (2) 2
5-aza-2'-deoxycytidine (1) 1
5-methylcytosine - analysis (1) 1
activation (1) 1
acute myeloid leukemia (1) 1
administration, oral (1) 1
alpha-v-beta-3 integrin (1) 1
analysis (1) 1
angiogenesis (1) 1
anthracyclines (1) 1
anthropometric characteristics (1) 1
antimetabolites, antineoplastic - administration & dosage (1) 1
antimetabolites, antineoplastic - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
apoptosis - drug effects (1) 1
au-rich element (1) 1
auto-sct (1) 1
azacitidine - administration & dosage (1) 1
azacitidine - adverse effects (1) 1
azacitidine - analogs & derivatives (1) 1
basic helix-loop-helix leucine zipper transcription factors - chemistry (1) 1
basic helix-loop-helix leucine zipper transcription factors - metabolism (1) 1
bcl-2 proteins (1) 1
beta-3-integrin (1) 1
bh3 mimetic abt-737 (1) 1
biocompatibility (1) 1
biomarkers (1) 1
biomarkers, tumor - analysis (1) 1
blast-crisis (1) 1
blood diseases (1) 1
body-mass index (1) 1
bone lesions (1) 1
bone marrow (1) 1
bone marrow - chemistry (1) 1
bone marrow - drug effects (1) 1
bone marrow - metabolism (1) 1
bone resorption - drug therapy (1) 1
bone resorption - etiology (1) 1
bone-marrow (1) 1
boronic acids - adverse effects (1) 1
breast-cancer (1) 1
c-myc (1) 1
c-myc/max dimerization (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 21, pp. 2023 - 2036
Journal Article
Leukemia, ISSN 0887-6924, 02/2013, Volume 27, Issue 2, pp. 430 - 440
Proteasome inhibitors (Pis), namely bortezomib, have become a cornerstone therapy for multiple myeloma (MM), potently reducing tumor burden and inhibiting... 
MULTIPLE-MYELOMA | CELLS | multiple myeloma | ACTIVATION | OSTEOBLAST DIFFERENTIATION | TGF-BETA | proteasome inhibitors | osteoblast | BORTEZOMIB | MURINE MODEL | UNFOLDED PROTEIN RESPONSE | ONCOLOGY | bone lesions | IN-VIVO | osteoclast | HEMATOLOGY | IRREVERSIBLE INHIBITOR | Stromal Cells - pathology | Humans | Pyrazines - administration & dosage | Multiple Myeloma - drug therapy | Epoxy Compounds - pharmacology | Bone Marrow - metabolism | Stromal Cells - drug effects | Boronic Acids - administration & dosage | Tumor Cells, Cultured | Real-Time Polymerase Chain Reaction | Bone Marrow - drug effects | Tumor Microenvironment - drug effects | Bone Resorption - etiology | Osteoclasts - pathology | Bortezomib | Calcification, Physiologic - drug effects | Administration, Oral | Multiple Myeloma - complications | Mice, Inbred C57BL | Osteoblasts - drug effects | Osteogenesis - drug effects | RNA, Messenger - genetics | Stromal Cells - metabolism | Bone Resorption - drug therapy | Mice, SCID | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Proteasome Inhibitors - therapeutic use | Osteoblasts - pathology | Animals | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cell Differentiation - drug effects | Bone Marrow - pathology | Mice, Inbred NOD | Cell Proliferation - drug effects | Mice | Oligopeptides - administration & dosage | Osteoclasts - drug effects | Usage | Enzyme inhibitors | Multiple myeloma | Carfilzomib | Drug therapy | Health aspects
Journal Article
ACS Symposium Series, ISSN 0097-6156, 2017, Volume 1271, pp. 189 - 209
Conference Proceeding
Bone Marrow Transplantation, ISSN 0268-3369, 05/2009, Volume 43, Issue 10, pp. 793 - 800
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2006, Volume 12, Issue 2, pp. 116 - 117
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2006, Volume 12, Issue 2, pp. 116 - 116
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2005, Volume 11, Issue 2, pp. 77 - 77
Journal Article
CANCER RESEARCH, ISSN 0008-5472, 06/2016, Volume 76, Issue 12, pp. 3484 - 3495
Integrin beta 3 is critical for tumor invasion, neoangiogenesis, and inflammation, making it a promising cancer target. However, preclinical and clinical data... 
BETA-3-INTEGRIN | ANGIOGENESIS | ONCOLOGY | RANDOMIZED PHASE-II | NEWLY-DIAGNOSED GLIOBLASTOMA | MACROPHAGES | ALPHA-V-BETA-3 INTEGRIN | INHIBITOR CILENGITIDE | BONE | TUMOR-GROWTH | T-CELLS
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 03/2019, Volume 25, Issue 3, pp. S399 - S400
Many studies showed that novel agent based regimens result in superior response rates and depth. Recommended practice prior to ASCT in TE, NDMM is novel... 
Anthracyclines | Dexamethasone | Multiple myeloma | Etoposide | Transplantation | Cisplatin | Cyclophosphamide | Chemotherapy | Analysis | Central nervous system depressants | Stem cells | Steroids | Cancer
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 08/2012, Volume 122, Issue 8, pp. 2793 - 2806
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 06/2015, Volume 14, Issue 6, pp. 1286 - 1294
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.